NCT05442463View on ClinicalTrials.gov

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Hormone Therapy
Interventions
DRUG

Captopril Tablets

Captorpril challenge to each participant

DRUG

Iohexol

Iohexol infusion to evaluate measured GFR

Trial Locations (1)

T2N 4Z6

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER